证券代码：301305 证券简称：朗坤科技 公告编号：2025-073 深圳市朗坤科技股份有限公司 关于股东及其一致行动人减持公司股份时间届满暨减持结 果的公告 一、股东减持情况 股东深圳华迪光大股权投资基金（有限合伙）、广东千灯华迪股权投资企业 （有限合伙）、广州盛隆投资合伙企业（有限合伙）、广州六脉资江股权投资合伙 企业（有限合伙）、贵州沛硕股权投资合伙企业（有限合伙）、广州资江凯源股权 投资合伙企业（有限合伙）和贵州享硕股权投资合伙企业（有限合伙）保证向本 公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 1、减持股份来源：公司首次公开发行前取得的股份 深圳市朗坤科技股份有限公司（以下简称"公司"）股东深圳华迪光大股权 投资基金（有限合伙）（以下简称"华迪光大"）、广东千灯华迪股权投资企业（有 限合伙）（以下简称"千灯华迪"）、广州盛隆投资合伙企业（有限合伙）（以下简 称"广州盛隆"）、广州六脉资江股权投资合伙企业（有限合伙）（以下简称"六 脉资江"）、贵州沛硕股权投资合伙企业（有限合伙）（以下简称"贵州沛硕"） ...

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field that disrupts traditional production methods, presenting it as a new growth point for optimizing industrial structures and transforming economic models. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper outlines the development status and trends of biomanufacturing, analyzing the global landscape and key platform facilities [5]. - It compares the biomanufacturing sectors of China and the United States, identifying competitive advantages and areas for improvement [5]. - Future development trends in biomanufacturing are discussed, indicating a shift towards more integrated and innovative approaches [5]. Group 2: Policy Landscape - The report reviews major policies affecting biomanufacturing both domestically and internationally, providing insights into regulatory frameworks that shape the industry [5]. - It categorizes foreign and domestic policies, highlighting their implications for the growth of the biomanufacturing sector [5]. Group 3: Industry Map and Applications - A comprehensive map of the Chinese biomanufacturing industry is presented, detailing key players and their roles [5]. - The report identifies critical application areas for biomanufacturing, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5]. Group 4: Key Enterprises and Investment Landscape - The white paper lists the top 10 leading enterprises in China's biomanufacturing sector, showcasing their contributions and market positions [6]. - It also summarizes the strategic directions of 15 publicly listed companies in synthetic biology, along with their investment and development strategies [6]. Group 5: Challenges and Recommendations - The report discusses the challenges faced by the biomanufacturing industry in China, including technological, regulatory, and market-related issues [6]. - Targeted policy recommendations are provided to address these challenges and promote sustainable growth in the biomanufacturing sector [6].

Group 1 - The company is currently in the trial production phase of its first phase project, which involves 260 tons of production capacity [2] - The production workshop is progressing in an orderly manner, indicating that operations are on track [2] - Investors are encouraged to monitor the company's future announcements for updates on the related business progress [2]

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field, which is seen as a new growth point that can drive industrial structure optimization and economic transformation. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper provides an overview of the global biomanufacturing industry, including its development status and trends [5]. - It compares the biomanufacturing sectors of China and the United States, highlighting competitive dynamics [5]. - Future development trends in biomanufacturing are discussed, indicating potential growth areas [5]. Group 2: Policy Landscape - The report outlines major policies affecting biomanufacturing both domestically and internationally for the years 2024-2025 [5]. - It details foreign biomanufacturing industry policies and their implications for the sector [5]. - Domestic policies related to biomanufacturing are also analyzed, providing insights into regulatory frameworks [5]. Group 3: Industry Map and Applications - The white paper presents a comprehensive map of the Chinese biomanufacturing industry, identifying key players and their roles [5]. - It analyzes the biomanufacturing industry chain and key application areas, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5][6]. - Specific applications of biomanufacturing in various sectors are highlighted, showcasing its versatility and potential impact [5]. Group 4: Key Enterprises and Investment Landscape - The report identifies ten leading enterprises in the Chinese biomanufacturing industry, providing insights into their operations and market positions [6]. - It summarizes the strategic directions of 15 listed companies in synthetic biology, indicating their focus areas and growth strategies [6]. - The investment landscape for synthetic biology in China is examined, detailing funding trends and opportunities from 2024 to mid-2025 [6]. Group 5: Challenges and Recommendations - The white paper discusses the challenges faced by the biomanufacturing industry in China, including technological, regulatory, and market-related issues [6]. - It offers targeted policy recommendations to address these challenges, aiming to support the sustainable development of the biomanufacturing sector [6].

一、担保事项概述 近日，公司与中国进出口银行深圳分行（以下简称"进出口银行"或"债权 人"）签署编号为 HETO20200001620250900000022-BZ01 的《保证合同》。约 定公司为控股子公司北京朗坤生物质新能源有限公司提供连带责任担保，担保的 主债权为进出口银行与公司控股子公司北京朗坤生物质新能源有限公司项目贷 款（贷款期限为自首次放款日起 180 个月），前述主债权本金余额最高不超过人 民币 1,000,000,000.00 元（大写：壹拾亿元整）为限。本合同项下被担保的最高 债权额，包括上述主债权本金，以及保证范围所约定的主债权之本金所产生的利 证券代码：301305 证券简称：朗坤科技 公告编号：2025-072 深圳市朗坤科技股份有限公司 关于为子公司提供担保事项的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳市朗坤科技股份有限公司（以下简称"公司"）分别于 2025 年 4 月 23 日、2025 年 5 月 16 日召开第三届董事会第二十二次会议、第三届监事会第十三 次会议以及 2024 年年度股东大会，审议通过了 ...

Investment Rating - The report does not explicitly state an investment rating for the industry Core Insights - In August, the electricity consumption growth rate in the secondary industry increased, contributing the largest increment to total electricity consumption, accounting for 59% of the total increase [3][7] - The total electricity consumption in August reached 10,154 billion kWh, a year-on-year increase of 5.0% [3][6] - The manufacturing sector saw a record monthly growth rate for the year, with high-tech and equipment manufacturing electricity consumption growing by 9.1%, surpassing the average manufacturing growth rate by approximately 4.6 percentage points [3][7] Summary by Sections 1. Electricity: August Secondary Industry Consumption Growth - The total electricity consumption in August was 10,154 billion kWh, with a year-on-year growth of 5.0% [3][6] - The first industry consumed 164 billion kWh (9.7% growth), the second industry consumed 5,981 billion kWh (5.0% growth), the third industry consumed 2,046 billion kWh (7.2% growth), and residential consumption was 1,963 billion kWh (2.4% growth) [3][8] - The secondary industry contributed the most to the total electricity consumption increase, with a significant growth in manufacturing, particularly in high-tech and equipment manufacturing [6][7] 2. Gas: Supply and Demand Stability - Global gas prices have shown narrow fluctuations, with the Henry Hub spot price at $2.90/mmBtu, a weekly increase of 0.17% [16][19] - The LNG national ex-factory price was 4,016 yuan/ton, with a slight weekly decrease of 0.07% [16][36] - The report suggests a positive outlook for city gas companies due to cost reductions and improved profitability [38] 3. Weekly Market Review - The public utility and environmental protection sectors underperformed compared to the CSI 300 index, while the electric equipment sector outperformed [40][42] 4. Company and Industry Dynamics - The report highlights recent government initiatives aimed at promoting high-quality development in energy equipment, focusing on enhancing the efficiency of energy conversion equipment and advancing renewable energy technologies [49] - Key announcements from companies include significant contract wins and strategic investments aimed at enhancing operational capabilities and market positioning [50]

Investment Rating - The report maintains a positive outlook on the power and gas sectors, recommending specific companies for investment based on their performance and market conditions [3][16][18]. Core Insights - The report highlights that in August, the total electricity consumption reached 10,154 billion kWh, marking a year-on-year growth of 5.0%. The second industry contributed the largest increase, accounting for 59% of the total electricity increment [3][8][9]. - The report notes that global gas prices are experiencing slight fluctuations, with the Henry Hub spot price at $2.90/mmBtu and the TTF spot price at €32.15/MWh as of September 26 [18][19]. - The report emphasizes the stable growth in electricity consumption driven by high temperatures and government policies aimed at boosting consumption [8][9]. Summary by Sections 1. Electricity Sector - In August, the second industry saw a significant increase in electricity consumption, with a year-on-year growth of 5.0% and contributing 59% to the total electricity increment [3][9]. - The manufacturing sector achieved a record monthly growth rate, particularly in high-tech and equipment manufacturing, which grew by 9.1% year-on-year [9][10]. - The report recommends investments in hydropower, green energy, nuclear power, and thermal power companies, citing favorable conditions for growth and profitability [16][17]. 2. Gas Sector - The report indicates that the supply-demand dynamics for gas remain stable, with slight fluctuations in global gas prices. The LNG price in Northeast Asia decreased by 2.61% to $11.20/mmBtu [18][19]. - It highlights the steady increase in U.S. natural gas inventories and the impact of mild weather on heating and cooling demands, leading to low price volatility [21][27]. - The report suggests focusing on integrated gas companies and city gas firms that are expected to benefit from cost reductions and improved profitability [41][42]. 3. Market Performance Review - The report notes that the public utility and environmental sectors underperformed compared to the Shanghai and Shenzhen 300 indices, while the power equipment sector outperformed [43][44]. 4. Company and Industry Dynamics - Recent government initiatives aim to enhance the quality of energy equipment and promote the development of renewable energy sources [52]. - The report includes updates on major companies' announcements, including contract wins and strategic investments, which are expected to positively impact their future performance [52][53]. 5. Key Company Valuation Table - The report provides a valuation table for key companies in the public utility and environmental sectors, indicating their market positions and potential for growth [54].

Group 1 - The rare earth permanent magnet sector experienced a significant upward trend on September 29, with notable stock performances [1] - Wolong New Energy reached the daily limit increase, while Hengdian East Magnetic surged over 8% [1] - Other companies such as Galaxy Magnet, Huicheng Environmental Protection, Lingyi Zhizao, and Greeenmei also saw increases in their stock prices [1]

Core Viewpoint - The rare earth permanent magnet sector is experiencing a significant upward trend, with notable stock price increases among key companies in the industry [1] Group 1: Company Performance - Wolong New Energy has reached its daily limit increase in stock price [1] - Hengdian East Magnetic has seen a stock price increase of over 8% [1] - Other companies such as Galaxy Magnetic, Huicheng Environmental Protection, Lingyi Zhizao, and Greeenmei have also experienced stock price increases [1]

Core Viewpoint - The company, Langkun Technology, has made significant progress in its HMO (Human Milk Oligosaccharides) project, which is now in the trial production phase, marking a substantial breakthrough in synthetic biology manufacturing [1] Group 1: HMO Project Development - The company's wholly-owned subsidiary, Langjian Biotechnology, has entered trial production for its first phase of HMO with an annual production capacity of 260 tons [1] - The second phase, with an expected annual capacity of 740 tons, is projected to commence production in 2026, bringing total capacity to 1,000 tons per year [1] - Langkun Technology has become the first domestic company approved for LNnT (Lactose-N-Tetraose) as a food additive, indicating a potential to disrupt the market dominated by foreign companies [1] - The future applications of HMOs extend beyond infant formula to health supplements and functional foods, suggesting a higher market ceiling [1] - The success of the HMO project validates the company's capability in producing high-end products using synthetic biology technology, which can be applied to develop other high-value products [1] Group 2: Traditional Business and Market Impact - The company's traditional business focuses on the harmless treatment and resource utilization of organic solid waste, including food waste and urban household waste [2] - The upcoming National Day and Mid-Autumn Festival holidays are expected to increase the volume of restaurant and household waste, positively impacting the company's short-term revenue [2] - Despite a 4.31% year-on-year decline in main revenue to 855 million yuan in the first half of 2025, the company reported a 22.36% increase in net profit attributable to shareholders, indicating strong profitability [1]